https://www.selleckchem.com/pr....oducts/leptomycinb.h
We present the case of an 85-year-old woman who presented to our clinic with neurogenic claudication due to lumbar spinal stenosis (LSS) over a period of two years. During this time a series of walking metrics were monitored including daily step count, walking speed, and step length. All metrics showed a deterioration over time and objectively document the disease progression of LSS (initial walking speed =1.03 m/s, step length =0.49 m, and daily step count =3,136; final walking speed =0.49 m/s, step length =0.37 m, and daily step c